Recent evidence shows that exogenous mutant p53 forms liquid droplets in the nucleolus of carcinoma cell lines, opening opportunities for studying the mechanism of oncogenic gain-of-function (Petronilho et al., 2021). Here, TP53 is linked to carcinoma.